Evidence map›Paper›PMID 31168172›Full record

ArticleActa clinica Croatica2018

THE RELATIONSHIP BETWEEN SERUM LEVEL OF MALONDIALDEHYDE AND PROGRESSION OF COLORECTAL CANCER.

Ismar Rašić, Azra Rašić, Goran Akšamija, Svjetlana Radović

Open access · diamondAbstract read
In one paragraph

Article in Acta clinica Croatica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in pharmacology · 2024
    Article
  11. Review
  12. Review
  13. Nanoliposome-Loaded Phenolics fromAnimals : an open access journal from MDPI · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ismar Rašić1Department of General and Abdominal Surgery, Sarajevo Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; 2Department of Oncology, Sarajevo Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; 3Department of Pathology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Azra Rašić1Department of General and Abdominal Surgery, Sarajevo Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; 2Department of Oncology, Sarajevo Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; 3Department of Pathology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Goran Akšamija1Department of General and Abdominal Surgery, Sarajevo Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; 2Department of Oncology, Sarajevo Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; 3Department of Pathology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Svjetlana Radović1Department of General and Abdominal Surgery, Sarajevo Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; 2Department of Oncology, Sarajevo Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina; 3Department of Pathology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
University of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

- The purpose of the study was to assess the level of serum malondialdehyde (MDA) concentration and its association with the stage and histopathologic sizes of colorectal cancer (CRC). One hundred and two patients having undergone surgical treatment of CRC between January 2014 and December 2015 were included in this cross-sectional study. The patients were divided into four groups (stage I-IV) according to the TNM classification. Control group included 30 subjects with no signs of malignancy and inflammatory diseases. In each patient, preoperative blood samples were obtained for determination of MDA concentration by ELISA immunoassay. Serum levels of MDA were progressively increased in patients with CRC, reaching the highest value in the fourth stage of CRC. Serum concentrations of MDA were significantly higher in pT4 group as compared with pT3 and pT2 groups of CRC patients (p<0.01). Significantly higher levels of MDA were found in the N1 and N2 groups of CRC patients as compared with N0 group, as well as in patients with metastatic disease as compared with those without metastasis (p<0.001). In conclusion, the progression of CRC is associated with a significant increase in serum MDA levels.

Indexed as

Colorectal NeoplasmsAgedBiomarkers, TumorBosnia and HerzegovinaCorrelation of DataCross-Sectional StudiesDisease ProgressionFemaleHumansMaleMalondialdehydeMiddle AgedNeoplasm MetastasisNeoplasm StagingOxidative StressPreoperative CareBiomarkers, TumorMalondialdehydeColonic neoplasmsCross-sectional studiesMalondialdehydeOxidative stress

Identifiers

PMID31168172
PMCPMC6536291
OpenAlexW2943147962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.